Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug

AIPROPX is tracking this story across the web and will keep this entry updated as coverage develops. Read the full report at the source below, and see related coverage further down.

Full report

Following

Method

Read the full report at STAT

Share

◆ AIPROPX index record

Region: Other
Detected names: AheadFDACapricor’s Duchenne

AIPROPX is an independent multi-source news index — we track, compare, and connect coverage from across the web into one place you won't find anywhere else.

Discover AIPROPX

LiveLive WireEvery report as it lands PopularTrendingMost-covered events now BrowseTop StoriesThe corroborated record FindSearchAny story, topic, or outlet